Literature DB >> 11063740

Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc.

J W Neal1, N A Clipstone.   

Abstract

The NFAT family of transcription factors is required for the expression of numerous immunologically important genes and plays a pivotal role in both the initiation and coordination of the immune response. NFAT family members appear to be regulated primarily at the level of their subcellular localization. Here we show that NFATc is additionally regulated at the level of its DNA binding activity. Using gel mobility shift assays, we demonstrate that the intrinsic DNA binding activity of NFATc is negatively regulated by phosphorylation. We found that activation of calcineurin activity in cells and dephosphorylation of NFATc in vitro enhanced NFATc DNA binding activity, whereas phosphorylation of NFATc in vitro inhibited its ability to bind DNA. Through the analysis of NFATc mutants, we identified the conserved Ser-Pro repeat motifs as critical quantitative determinants of NFATc DNA binding activity. In addition, we provide several lines of evidence to suggest that the phosphorylation of the Ser-Pro repeats by glycogen synthase kinase-3 inhibits the ability of NFATc to bind DNA. Taken together, these studies afford new insights into the regulation of NFATc and underscore the potential role of glycogen synthase kinase-3 in the regulation of NFAT-dependent gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063740     DOI: 10.1074/jbc.M004888200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1.

Authors:  Heidi Okamura; Carmen Garcia-Rodriguez; Holly Martinson; Jun Qin; David M Virshup; Anjana Rao
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

2.  NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching.

Authors:  Karl J A McCullagh; Elisa Calabria; Giorgia Pallafacchina; Stefano Ciciliot; Antonio L Serrano; Carla Argentini; John M Kalhovde; Terje Lømo; Stefano Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

Review 3.  Primers on molecular pathways--the NFAT transcription pathway in pancreatic cancer.

Authors:  Alexander König; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Pancreatology       Date:  2010-08-19       Impact factor: 3.996

4.  Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3{beta} inhibition.

Authors:  Jay A Graham; Michael Fray; Stephanie de Haseth; Kang Mi Lee; Moh-Moh Lian; Catharine M Chase; Joren C Madsen; James Markmann; Gilles Benichou; Robert B Colvin; A Benedict Cosimi; Shaoping Deng; James Kim; Alessandro Alessandrini
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 5.  GSK3 signalling in neural development.

Authors:  Eun-Mi Hur; Feng-Quan Zhou
Journal:  Nat Rev Neurosci       Date:  2010-08       Impact factor: 34.870

6.  Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Authors:  Malte Buchholz; Alexandra Schatz; Martin Wagner; Patrick Michl; Thomas Linhart; Guido Adler; Thomas M Gress; Volker Ellenrieder
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

7.  Regulation of the nuclear export of the transcription factor NFATc1 by protein kinases after slow fibre type electrical stimulation of adult mouse skeletal muscle fibres.

Authors:  Tiansheng Shen; Zoltán Cseresnyés; Yewei Liu; William R Randall; Martin F Schneider
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

Review 8.  NFAT signaling in neural development and axon growth.

Authors:  Tuan Nguyen; Simone Di Giovanni
Journal:  Int J Dev Neurosci       Date:  2007-11-17       Impact factor: 2.457

9.  Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells.

Authors:  Whitney S Helms; Jerry L Jeffrey; Derek A Holmes; Michael B Townsend; Neil A Clipstone; Lishan Su
Journal:  J Leukoc Biol       Date:  2007-05-14       Impact factor: 4.962

Review 10.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.